The call has ended.
Key takeaways
Q2 FY27 record quarter: revenue ₹3,610 Mn (+63.9% YoY), EBITDA ₹387 Mn (10.72% margin), PAT ₹280 Mn (+86.7% YoY). H1 PAT ₹541 Mn. Capacity expansion underway.
| Revenue growth | Q2 +63.9% YoY; H1 +54.4% YoY |
|---|---|
| Margins | Q2 EBITDA margin 10.72%, up 78 bps YoY |
| Demand visibility | Auto volumes strong; ~₹25,000 Cr tyre capex announced |
| Management confidence | Expects further margin improvement as capacity ramps |
Growth
Q2 revenue +63.9% YoY and PAT +86.7% YoY. H1 revenue +54.4% and PAT +72.3% YoY.
Outlook
Dahej Phase 1 trials next month; Naidupeta expansion due Q4 FY27; total ZnO capacity 79,904 MTPA. Margin improvement expected.
Risks
West Asia disruptions, higher energy and freight costs, and global zinc scrap sourcing volatility. Capacity ramp-up execution risk.
Summary by ALFA Finder, written with AI assistance from the earnings call transcript the company filed, published . Open it on ALFA Filings ›
The results behind this call
J G Chemicals Q2 FY27 Results: Net Profit ₹28 Cr, Up 86.7% YoY
J G Chemicals Ltd reported revenue from operations of ₹361 Cr (+63.9% YoY) and net profit of ₹28 Cr (+86.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28 Cr · +86.7% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
Dahej project commissioning in H1-FY27; targeting 30% non-rubber revenue contribution; INR 100 Cr investment funded internally.
Growth they described
FY26 revenue rose 14.7% to INR 9,729 Mn; PAT increased 2.7% to INR 686 Mn.
Call details
| Company | J.g.chemicals Ltd |
|---|---|
| NSE symbol | JGCHEM |
| ISIN | INE0MB501011 |
| Call | Q2 FY27 earnings call |
| Date | Wednesday, 4 November 2026 |
| Time | 4:00 PM IST |
J.g.chemicals Ltd: key numbers
- Share price
- ₹582.05
- Market cap
- ₹2,281 Cr
- Revenue (annual)
- ₹972.9 Cr
- Net profit (annual)
- ₹65.88 Cr
- P/E (TTM)
- 26.1×Sector 28.2×
- Promoter holding
- 70.99%+0.00% QoQ
- FII holding
- 3.77%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.